e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
COPD: treatment and monitoring
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Exhaled nitric oxide measures using multiple flows in clinically relevant subgroups of COPD
N. Bazeghi, T. Gerds, E. Budtz-Joergensen, J. Hove, J. Vestbo (Copenhagen, Denmark; , United Kingdom)
Source:
Annual Congress 2010 - COPD: treatment and monitoring
Session:
COPD: treatment and monitoring
Session type:
Thematic Poster Session
Number:
1337
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Bazeghi, T. Gerds, E. Budtz-Joergensen, J. Hove, J. Vestbo (Copenhagen, Denmark; , United Kingdom). Exhaled nitric oxide measures using multiple flows in clinically relevant subgroups of COPD. Eur Respir J 2010; 36: Suppl. 54, 1337
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Imaging of complicated pneumonia: what is new?
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
Exhaled nitric oxide as a biomarker in different COPD phenotypes
Source: International Congress 2018 – Biomarkers for evaluating COPD
Year: 2018
Exhaled nitric oxide is related to asthma control but not severity
Source: Eur Respir J 2004; 24: Suppl. 48, 260s
Year: 2004
Exhaled nitric oxide in the assessment of asthma control
Source: Eur Respir J 2007; 30: Suppl. 51, 18s
Year: 2007
Exhaled nitric oxide and COPD
Source: Eur Respir J 2010; 36: 692
Year: 2010
Exhaled nitric oxide and pulmonary function tests in children with asthma
Source: Eur Respir J 2007; 30: Suppl. 51, 759s
Year: 2007
Reproducibility of exhaled nitric oxide measurements in healthy and asthmatic adults and children
Source: Eur Respir J 2003; 21: 433-438
Year: 2003
Exhaled nitric oxide as a predictor of exacerbations of asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 307s
Year: 2004
Comparison of three different exhaled nitric oxide analyzers in asthma and COPD
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
Exhaled nitric oxide and clinical phenotype of childhood asthma
Source: Annual Congress 2011 - Inflammation and genes in childhood asthma
Year: 2011
Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients
Source: Eur Respir J 2008; 31: 539-546
Year: 2008
Exhaled nitric oxide in children with severe asthma
Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood
Year: 2012
Is exhaled nitric oxide (eNO) an indipendent outcome measure in chronic stable asthma?
Source: Eur Respir J 2002; 20: Suppl. 38, 196s
Year: 2002
Exhaled nitric oxide values measured at 10ml/s influence assessments of bronchial nitric oxide flux
Source: Eur Respir J 2006; 28: Suppl. 50, 792s
Year: 2006
Exhaled nitric oxide predicts response to treatment in COPD patients with exacerbation
Source: Annual Congress 2008 - Phenotyping of asthma and COPD
Year: 2008
Exhaled nitric oxide correlations in patients with controlled and partially controlled asthma
Source: Annual Congress 2012 - Asthma management
Year: 2012
Exhaled and nasal nitric oxide measurements: recommendations
Source: Guideline 1997
Year: 1997
Predicting response to corticosteroid in COPD using exhaled nitric oxide
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009
Fractionated exhaled nitric oxide in COPD patients
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019
Technical problems with measurements of biomarkers - exhaled nitric oxide
Source: ERS Skills course - Biomarkers and functional assessment of obstructive lung diseases
Year: 2017
Exhaled nitric oxide and blood eosinophilia: biomarkers of different adult asthma phenotypes
Source: International Congress 2017 – Monitoring asthma control
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept